MVA2
MCID: MSC106
MIFTS: 30

Mosaic Variegated Aneuploidy Syndrome 2 (MVA2)

Categories: Cancer diseases, Eye diseases, Fetal diseases, Genetic diseases, Neuronal diseases, Rare diseases

Aliases & Classifications for Mosaic Variegated Aneuploidy Syndrome 2

MalaCards integrated aliases for Mosaic Variegated Aneuploidy Syndrome 2:

Name: Mosaic Variegated Aneuploidy Syndrome 2 58 12 76 30 13 6 74
Mva2 58 76
Mosaic Variegated Aneuploidy Syndrome, Type 2 41

Characteristics:

OMIM:

58
Inheritance:
autosomal recessive

Miscellaneous:
highly variable phenotype
four patients have been reported (as of july 2011)
facial dysmorphic features are mild


HPO:

33
mosaic variegated aneuploidy syndrome 2:
Inheritance autosomal recessive inheritance


Classifications:



Summaries for Mosaic Variegated Aneuploidy Syndrome 2

UniProtKB/Swiss-Prot : 76 Mosaic variegated aneuploidy syndrome 2: A severe developmental disorder characterized by mosaic aneuploidies, predominantly trisomies and monosomies, involving multiple different chromosomes and tissues. Affected individuals typically present with severe intrauterine growth retardation and microcephaly. Eye anomalies, mild dysmorphism, variable developmental delay, and a broad spectrum of additional congenital abnormalities and medical conditions may also occur. The risk of malignancy is high, with rhabdomyosarcoma, Wilms tumor and leukemia reported in several cases.

MalaCards based summary : Mosaic Variegated Aneuploidy Syndrome 2, also known as mva2, is related to mosaic variegated aneuploidy syndrome. An important gene associated with Mosaic Variegated Aneuploidy Syndrome 2 is CEP57 (Centrosomal Protein 57). The drugs Vaccines and Immunologic Factors have been mentioned in the context of this disorder. Affiliated tissues include eye, heart and lung, and related phenotypes are low-set ears and frontal bossing

OMIM : 58 Mosaic variegated aneuploidy syndrome is an autosomal recessive disorder characterized by poor growth and variable phenotypic manifestations, such as facial dysmorphism and congenital heart defects, associated with mosaic aneuploidies resulting from defects in cell division (summary by Snape et al., 2011). See also MVA1 (257300), caused by mutation in the BUB1B gene (602860) on chromosome 15q15. (614114)

Related Diseases for Mosaic Variegated Aneuploidy Syndrome 2

Diseases in the Mosaic Variegated Aneuploidy Syndrome family:

Mosaic Variegated Aneuploidy Syndrome 1 Mosaic Variegated Aneuploidy Syndrome 2
Mosaic Variegated Aneuploidy Syndrome 3

Diseases related to Mosaic Variegated Aneuploidy Syndrome 2 via text searches within MalaCards or GeneCards Suite gene sharing:

# Related Disease Score Top Affiliating Genes
1 mosaic variegated aneuploidy syndrome 9.5 CEP57 FAM76B

Symptoms & Phenotypes for Mosaic Variegated Aneuploidy Syndrome 2

Human phenotypes related to Mosaic Variegated Aneuploidy Syndrome 2:

33 (show all 34)
# Description HPO Frequency HPO Source Accession
1 low-set ears 33 very rare (1%) HP:0000369
2 frontal bossing 33 very rare (1%) HP:0002007
3 hypothyroidism 33 very rare (1%) HP:0000821
4 sleep apnea 33 very rare (1%) HP:0010535
5 hearing impairment 33 very rare (1%) HP:0000365
6 delayed skeletal maturation 33 very rare (1%) HP:0002750
7 depressed nasal bridge 33 very rare (1%) HP:0005280
8 short nose 33 very rare (1%) HP:0003196
9 intellectual disability, mild 33 very rare (1%) HP:0001256
10 micrognathia 33 very rare (1%) HP:0000347
11 epicanthus 33 very rare (1%) HP:0000286
12 dolichocephaly 33 very rare (1%) HP:0000268
13 deeply set eye 33 very rare (1%) HP:0000490
14 downslanted palpebral fissures 33 very rare (1%) HP:0000494
15 long face 33 very rare (1%) HP:0000276
16 blepharophimosis 33 very rare (1%) HP:0000581
17 triangular face 33 very rare (1%) HP:0000325
18 generalized hypotonia 33 very rare (1%) HP:0001290
19 abnormal lung lobation 33 very rare (1%) HP:0002101
20 duodenal atresia 33 very rare (1%) HP:0002247
21 short palpebral fissure 33 very rare (1%) HP:0012745
22 cafe-au-lait spot 33 very rare (1%) HP:0000957
23 growth hormone deficiency 33 very rare (1%) HP:0000824
24 epidermoid cyst 33 very rare (1%) HP:0200040
25 clinodactyly 33 HP:0030084
26 microcephaly 33 HP:0000252
27 short stature 33 HP:0004322
28 intrauterine growth retardation 33 HP:0001511
29 atrial septal defect 33 HP:0001631
30 coarctation of aorta 33 HP:0001680
31 ventricular septal defect 33 HP:0001629
32 aortic regurgitation 33 HP:0001659
33 small for gestational age 33 HP:0001518
34 subvalvular aortic stenosis 33 HP:0001682

Symptoms via clinical synopsis from OMIM:

58
Head And Neck Head:
microcephaly
temporal bossing (in 1/4 patients)
frontal bossing (in 1/4 patients)
narrow head (in 1/4 patients)
dolichocephaly (in 2/4 patients)

Cardiovascular Heart:
atrial septal defect
ventricular septal defect
aortic valve regurgitation
congenital heart defects (in 2/4 patients)

Growth Weight:
low birth weight
intrauterine growth retardation (iugr)

Head And Neck Face:
long face (in 1/4 patients)
triangular face (in 2/4 patients)
micrognathia (in 2/4 patients)

Head And Neck Eyes:
deep-set eyes (in 1/4 patients)
short palpebral fissures (in 1/4 patients)
downslanting palpebral fissures (in 2/4 patients)
epicanthal folds (3/4 patients)

Respiratory Lung:
abnormal lung lobation (in 1/4 patients)

Skeletal:
delayed bone age (in 1/4 patients)

Skeletal Limbs:
rhizomelic shortening of the upper limbs (in 2/4 patients)

Skin Nails Hair Skin:
cafe-au-lait spot (in 1/4 patients)

Endocrine Features:
growth hormone deficiency (in 1/4 patients)
hypothyroidism (in 2/4 patients)

Growth Height:
short stature

Cardiovascular Vascular:
subaortic stenosis
aortic coarctation

Growth Other:
poor growth

Head And Neck Ears:
hearing impairment (in 1/4 patients)
low-set ears (in 2/4 patients)

Head And Neck Nose:
small nose (in 2/4 patients)
flat nasal bridge (in 2/4 patients)

Abdomen Gastrointestinal:
duodenal atresia (in 1/4 patients)

Skeletal Skull:
epidermoid cysts (in 1/4 patients)

Skeletal Hands:
clinodactyly (in 2/4 patients)

Neurologic Central Nervous System:
mild mental retardation (in 1/4 patients)
hypotonia (in 1/4 patients)
sleep apnea (in 1/4 patients)

Laboratory Abnormalities:
mitotic lymphocyte and fibroblast cultures show mosaic variegated aneuploidy (50%) affecting all chromosomes
chromosomal structural abnormalities

Clinical features from OMIM:

614114

GenomeRNAi Phenotypes related to Mosaic Variegated Aneuploidy Syndrome 2 according to GeneCards Suite gene sharing:

27
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Decreased shRNA abundance GR00251-A-1 9.23 CEP57 FAM76B
2 Decreased shRNA abundance GR00251-A-2 9.23 CEP57 FAM76B

Drugs & Therapeutics for Mosaic Variegated Aneuploidy Syndrome 2

Drugs for Mosaic Variegated Aneuploidy Syndrome 2 (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):


# Name Status Phase Clinical Trials Cas Number PubChem Id
1 Vaccines Phase 1
2 Immunologic Factors Phase 1

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Combination Study With MVA BN and Dryvax Completed NCT00082446 Phase 1

Search NIH Clinical Center for Mosaic Variegated Aneuploidy Syndrome 2

Genetic Tests for Mosaic Variegated Aneuploidy Syndrome 2

Genetic tests related to Mosaic Variegated Aneuploidy Syndrome 2:

# Genetic test Affiliating Genes
1 Mosaic Variegated Aneuploidy Syndrome 2 30 CEP57

Anatomical Context for Mosaic Variegated Aneuploidy Syndrome 2

MalaCards organs/tissues related to Mosaic Variegated Aneuploidy Syndrome 2:

42
Eye, Heart, Lung, Bone

Publications for Mosaic Variegated Aneuploidy Syndrome 2

Articles related to Mosaic Variegated Aneuploidy Syndrome 2:

# Title Authors Year
1
CEP57 mutation in a girl with mosaic variegated aneuploidy syndrome. ( 24259107 )
2014
2
Mutations in CEP57 cause mosaic variegated aneuploidy syndrome. ( 21552266 )
2011
3
Clinical and genetic heterogeneity in patients with mosaic variegated aneuploidy: delineation of clinical subtypes. ( 18548531 )
2008
4
Mosaic variegated aneuploidy with growth hormone deficiency and congenital heart defects. ( 12116237 )
2002

Variations for Mosaic Variegated Aneuploidy Syndrome 2

ClinVar genetic disease variations for Mosaic Variegated Aneuploidy Syndrome 2:

6 (show top 50) (show all 92)
# Gene Variation Type Significance SNP ID Assembly Location
1 CEP57 NM_014679.4(CEP57): c.520_521delGA (p.Glu174Thrfs) deletion Pathogenic GRCh38 Chromosome 11, 95817802: 95817803
2 CEP57 NM_014679.4(CEP57): c.520_521delGA (p.Glu174Thrfs) deletion Pathogenic GRCh37 Chromosome 11, 95550966: 95550967
3 CEP57 NM_014679.3(CEP57): c.915_925dup (p.Leu309Profs) duplication Pathogenic rs1166323407 GRCh38 Chromosome 11, 95827815: 95827825
4 CEP57 NM_014679.3(CEP57): c.915_925dup (p.Leu309Profs) duplication Pathogenic rs1166323407 GRCh37 Chromosome 11, 95560979: 95560989
5 CEP57 NM_014679.4(CEP57): c.241C> T (p.Arg81Ter) single nucleotide variant Pathogenic rs387906977 GRCh37 Chromosome 11, 95546134: 95546134
6 CEP57 NM_014679.4(CEP57): c.241C> T (p.Arg81Ter) single nucleotide variant Pathogenic rs387906977 GRCh38 Chromosome 11, 95812970: 95812970
7 CEP57 NM_014679.4(CEP57): c.4G> A (p.Ala2Thr) single nucleotide variant Uncertain significance rs878854985 GRCh38 Chromosome 11, 95790702: 95790702
8 CEP57 NM_014679.4(CEP57): c.4G> A (p.Ala2Thr) single nucleotide variant Uncertain significance rs878854985 GRCh37 Chromosome 11, 95523866: 95523866
9 CEP57 NM_014679.4(CEP57): c.807+3G> A single nucleotide variant Benign rs181776180 GRCh38 Chromosome 11, 95821981: 95821981
10 CEP57 NM_014679.4(CEP57): c.807+3G> A single nucleotide variant Benign rs181776180 GRCh37 Chromosome 11, 95555145: 95555145
11 CEP57 NM_014679.4(CEP57): c.1036T> C (p.Leu346=) single nucleotide variant Benign rs34254650 GRCh38 Chromosome 11, 95827936: 95827936
12 CEP57 NM_014679.4(CEP57): c.1036T> C (p.Leu346=) single nucleotide variant Benign rs34254650 GRCh37 Chromosome 11, 95561100: 95561100
13 CEP57 NM_014679.4(CEP57): c.572T> A (p.Leu191His) single nucleotide variant Uncertain significance rs150399616 GRCh37 Chromosome 11, 95551018: 95551018
14 CEP57 NM_014679.4(CEP57): c.572T> A (p.Leu191His) single nucleotide variant Uncertain significance rs150399616 GRCh38 Chromosome 11, 95817854: 95817854
15 CEP57 NM_014679.4(CEP57): c.753G> A (p.Pro251=) single nucleotide variant Benign rs11742 GRCh37 Chromosome 11, 95555088: 95555088
16 CEP57 NM_014679.4(CEP57): c.753G> A (p.Pro251=) single nucleotide variant Benign rs11742 GRCh38 Chromosome 11, 95821924: 95821924
17 CEP57 NM_014679.4(CEP57): c.807+8G> A single nucleotide variant Benign rs117602509 GRCh37 Chromosome 11, 95555150: 95555150
18 CEP57 NM_014679.4(CEP57): c.807+8G> A single nucleotide variant Benign rs117602509 GRCh38 Chromosome 11, 95821986: 95821986
19 CEP57 NM_014679.4(CEP57): c.798A> G (p.Pro266=) single nucleotide variant Benign rs61903295 GRCh37 Chromosome 11, 95555133: 95555133
20 CEP57 NM_014679.4(CEP57): c.798A> G (p.Pro266=) single nucleotide variant Benign rs61903295 GRCh38 Chromosome 11, 95821969: 95821969
21 CEP57 NM_014679.4(CEP57): c.1214T> C (p.Val405Ala) single nucleotide variant Uncertain significance rs763862458 GRCh37 Chromosome 11, 95562437: 95562437
22 CEP57 NM_014679.4(CEP57): c.1214T> C (p.Val405Ala) single nucleotide variant Uncertain significance rs763862458 GRCh38 Chromosome 11, 95829273: 95829273
23 CEP57 NM_014679.4(CEP57): c.333G> C (p.Gln111His) single nucleotide variant Benign rs117321017 GRCh37 Chromosome 11, 95546226: 95546226
24 CEP57 NM_014679.4(CEP57): c.333G> C (p.Gln111His) single nucleotide variant Benign rs117321017 GRCh38 Chromosome 11, 95813062: 95813062
25 CEP57 NM_014679.4(CEP57): c.451C> A (p.Arg151=) single nucleotide variant Likely benign rs771182933 GRCh37 Chromosome 11, 95546700: 95546700
26 CEP57 NM_014679.4(CEP57): c.451C> A (p.Arg151=) single nucleotide variant Likely benign rs771182933 GRCh38 Chromosome 11, 95813536: 95813536
27 CEP57 NM_014679.4(CEP57): c.520G> C (p.Glu174Gln) single nucleotide variant Uncertain significance rs1060501986 GRCh37 Chromosome 11, 95550966: 95550966
28 CEP57 NM_014679.4(CEP57): c.520G> C (p.Glu174Gln) single nucleotide variant Uncertain significance rs1060501986 GRCh38 Chromosome 11, 95817802: 95817802
29 CEP57 NM_014679.4(CEP57): c.979A> G (p.Ile327Val) single nucleotide variant Benign rs35604386 GRCh37 Chromosome 11, 95561043: 95561043
30 CEP57 NM_014679.4(CEP57): c.979A> G (p.Ile327Val) single nucleotide variant Benign rs35604386 GRCh38 Chromosome 11, 95827879: 95827879
31 CEP57 NM_014679.4(CEP57): c.422A> G (p.Asn141Ser) single nucleotide variant Uncertain significance rs149196489 GRCh38 Chromosome 11, 95813507: 95813507
32 CEP57 NM_014679.4(CEP57): c.422A> G (p.Asn141Ser) single nucleotide variant Uncertain significance rs149196489 GRCh37 Chromosome 11, 95546671: 95546671
33 CEP57 NM_014679.4(CEP57): c.917A> G (p.Asn306Ser) single nucleotide variant Uncertain significance rs557536640 GRCh38 Chromosome 11, 95827817: 95827817
34 CEP57 NM_014679.4(CEP57): c.917A> G (p.Asn306Ser) single nucleotide variant Uncertain significance rs557536640 GRCh37 Chromosome 11, 95560981: 95560981
35 CEP57 NM_014679.4(CEP57): c.1008A> G (p.Val336=) single nucleotide variant Likely benign rs933546735 GRCh37 Chromosome 11, 95561072: 95561072
36 CEP57 NM_014679.4(CEP57): c.1008A> G (p.Val336=) single nucleotide variant Likely benign rs933546735 GRCh38 Chromosome 11, 95827908: 95827908
37 CEP57 NM_014679.4(CEP57): c.677G> A (p.Arg226His) single nucleotide variant Likely benign rs143711180 GRCh38 Chromosome 11, 95818882: 95818882
38 CEP57 NM_014679.4(CEP57): c.677G> A (p.Arg226His) single nucleotide variant Likely benign rs143711180 GRCh37 Chromosome 11, 95552046: 95552046
39 CEP57 NM_014679.4(CEP57): c.925C> T (p.Leu309Phe) single nucleotide variant Likely benign rs548800686 GRCh38 Chromosome 11, 95827825: 95827825
40 CEP57 NM_014679.4(CEP57): c.925C> T (p.Leu309Phe) single nucleotide variant Likely benign rs548800686 GRCh37 Chromosome 11, 95560989: 95560989
41 CEP57 NM_014679.4(CEP57): c.510C> G (p.Ser170=) single nucleotide variant Likely benign rs201373134 GRCh37 Chromosome 11, 95550956: 95550956
42 CEP57 NM_014679.4(CEP57): c.510C> G (p.Ser170=) single nucleotide variant Likely benign rs201373134 GRCh38 Chromosome 11, 95817792: 95817792
43 CEP57 NM_014679.4(CEP57): c.751C> T (p.Pro251Ser) single nucleotide variant Uncertain significance rs149293164 GRCh38 Chromosome 11, 95821922: 95821922
44 CEP57 NM_014679.4(CEP57): c.751C> T (p.Pro251Ser) single nucleotide variant Uncertain significance rs149293164 GRCh37 Chromosome 11, 95555086: 95555086
45 CEP57 NM_014679.4(CEP57): c.1297_1305delCAGAAGAAG (p.Gln433_Lys435del) deletion Uncertain significance rs761197192 GRCh37 Chromosome 11, 95564214: 95564222
46 CEP57 NM_014679.4(CEP57): c.1297_1305delCAGAAGAAG (p.Gln433_Lys435del) deletion Uncertain significance rs761197192 GRCh38 Chromosome 11, 95831050: 95831058
47 CEP57 NM_014679.4(CEP57): c.65C> T (p.Ser22Leu) single nucleotide variant Uncertain significance rs554897859 GRCh37 Chromosome 11, 95532415: 95532415
48 CEP57 NM_014679.4(CEP57): c.65C> T (p.Ser22Leu) single nucleotide variant Uncertain significance rs554897859 GRCh38 Chromosome 11, 95799251: 95799251
49 CEP57 NM_014679.4(CEP57): c.95C> T (p.Ser32Phe) single nucleotide variant Uncertain significance rs139110744 GRCh37 Chromosome 11, 95532445: 95532445
50 CEP57 NM_014679.4(CEP57): c.95C> T (p.Ser32Phe) single nucleotide variant Uncertain significance rs139110744 GRCh38 Chromosome 11, 95799281: 95799281

Expression for Mosaic Variegated Aneuploidy Syndrome 2

Search GEO for disease gene expression data for Mosaic Variegated Aneuploidy Syndrome 2.

Pathways for Mosaic Variegated Aneuploidy Syndrome 2

GO Terms for Mosaic Variegated Aneuploidy Syndrome 2

Sources for Mosaic Variegated Aneuploidy Syndrome 2

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....